Market Place
Sourcing Support
Latest biotech merger sees aimless Adamis snapped up by DMK
28 Feb 2023 //
FIERCE BIOTECH
Adamis’ shares nosedive as sole clinical-stage asset flunks COVID-19 trial
22 Sep 2022 //
FIERCEBIOTECH
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive
21 Sep 2022 //
GLOBENEWSWIRE
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol
13 Sep 2022 //
PRESS RELEASE
Adamis to continue Phase II/III trial of Tempol for Covid-19
02 Jun 2022 //
CLINICALTRIALSARENA
Adamis Doses 1st Patient in Phase 2/3 Clinical Trial for Tempol in COVID-19
02 Sep 2021 //
GLOBENEWSWIRE
Adamis Cleared to Proceed with Human Studies of Tempol for COVID-19
22 Feb 2021 //
ADAMISPHARMACEUTICALS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.